TOKYO--(BUSINESS WIRE)--Modulus Discovery, Inc., a preclinical-stage computation-driven drug discovery firm, announces the successful closing of its Series C funding round in the amount of 2.34B JPY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback